Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE

Sponsor
Medical College of Wisconsin (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05993689
Collaborator
(none)
412
2
81

Study Details

Study Description

Brief Summary

The BUNDLE study is a prospective mixed-methods study focused on the early integration of community doula into prenatal care. The study will have three phases: Phase 1 is the qualitative phase of conducting focus groups with Black/African American (AA) birthing people and with medical and community healthcare providers to elicit feedback on how best to integrate community-based doulas and obstetricians into one united model of prenatal care to promote trust and improved maternal health outcomes. Phase 2 tests the effectiveness of the newly developed model on healthcare engagement, trust, and adverse maternal outcomes using randomized control trial of 412 Black/AA pregnant participants. Phase 3 is dissemination of BUNDLE findings in scholarly and community-based forums, including with healthcare leaders and policy makers in Wisconsin, advocating for doula coverage and health system sustainability of the integrated model.

Condition or Disease Intervention/Treatment Phase
  • Other: BUNDLE
  • Other: Usual Care
N/A

Detailed Description

The BUNDLE study is a prospective mixed-methods study focused on the early integration of community doula into prenatal care. The investigators will pursue the following aims using a multidisciplinary team of experts in health disparities, community engagement, qualitative research, maternal-fetal medicine, and doula support:

Aim 1: Develop an integrated prenatal care model of medical providers and community doulas in Southeastern Wisconsin Approach: The investigators will conduct six focus groups with 30 Black/AA birthing people (currently pregnant or recently postpartum) and 30 prenatal healthcare providers (obstetricians, midwives, doulas, social workers, prenatal care coordinators, nurses, mental health providers, and obstetric unit leaders) to elicit feedback on models of doula/medical provider integration with the overarching aim of building trust and improving maternal health outcomes. Focus group findings will be reviewed with a community advisory panel (CAP) developed as part of the Community Partnership of the MCW U54 center, to gain the CAP's input on intervention development.

Aim 2: Compare the effectiveness of the integrated prenatal care model to standard prenatal care in improving healthcare engagement and trust and reducing adverse maternal outcomes Approach: In a two-arm randomized controlled trial conducted at Froedtert and MCW, the investigators will randomize 412 Black/AA pregnant people to BUNDLE or standard prenatal care. Primary outcome is healthcare engagement (starting prenatal care in 1st trimester, attending at least 70% of the recommended visits, attending the postpartum visit, and receipt of recommended vaccination during pregnancy). Secondary outcomes include medical mistrust measured by trust in provider scale, perceived discrimination, and frequencies of severe maternal morbidity as defined by the Centers for Disease Control.

Aim 3: Disseminate findings to scholarly and community-based forums and actively pursue opportunities for systems- and policy-level change Approach: The investigators will disseminate findings regularly in scholarly (conference, grand rounds) and community-based (listening session, town hall) forums. The investigators will leverage the existing partnerships with policymakers, healthcare organizations, and community leaders to implement strategies to sustain successful program outcomes through policy changes at the system and statewide level by advocating for doula coverage and healthcare system sustainability of the integrated prenatal care model.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
412 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Jun 30, 2030
Anticipated Study Completion Date :
Jun 30, 2030

Arms and Interventions

Arm Intervention/Treatment
Experimental: BUNDLE Intervention

Proposed components of the intervention will include: 1) attendance at two visits in the 2nd trimester and two visits in the 3rd trimester by a doula; 2) exchange of contact information between the clinic and the doula; 3) exchange of social needs and social-structural risk factors complicating patient's prenatal care from doula and exchange of clinical risk factors complicating prenatal care from obstetric provider; 4) communication between the doula and provider; 5) educating the obstetric team on benefits of doula support; 6) preparing labor and delivery team for presence of doula during labor ; and 7) enhancing doula support postpartum for cardiovascular risk reduction.

Other: BUNDLE
An integrated model of community-based doulas and clinical obstetric providers

Active Comparator: Usual Care

Standard of care for pregnancy and pregnancy-related issues will be provided by the obstetric provider as per routine.

Other: Usual Care
Standard of care for pregnancy and pregnancy-related issues by the obstetric provider

Outcome Measures

Primary Outcome Measures

  1. Perinatal Healthcare Engagement [From study enrollment and until 12 months postpartum]

    A composite of the following variables to assess perinatal healthcare engagement: 1) Attended at least ~75% of the recommended prenatal visits; 2) Attended postpartum visit; 3) Received recommended vaccination during pregnancy.

Secondary Outcome Measures

  1. Trust in Provider [Baseline; third trimester, and postpartum]

    A validated 11-item instrument used to measure patients' trust in the provider regarding dependability, confidence, and confidentiality of information.

  2. Reported Discrimination [Baseline, third trimester and postpartum]

    Measured with a validated survey of patient self-report on how often in the past 12 months, individuals felt treated poorly due to race.

  3. Perceived Stress [Baseline, third trimester and postpartum]

    Measured with Cohen's Perceived Stress Scale

  4. Depression [Baseline, third trimester and postpartum]

    Measured with the Patient Health Questionnaire-9 (PHQ-9)

  5. Cesarean birth [At study completion]

    Cesarean birth for any indication other than prior cesarean

  6. Unplanned healthcare utilization [Up to 12 months postpartum]

    Prenatal or postpartum (up to 12 weeks postpartum) unplanned emergency room visits or hospitalizations.

  7. Severe Maternal Morbidity [Up to 12 months postpartum]

    Composite outcome of the following diagnoses using ICD-10 codes: acute myocardial infarction, aneurysm, acute renal failure, adult respiratory distress syndrome, amniotic fluid embolism, cardiac arrest, disseminated intravascular coagulation, eclampsia, heart failure, puerperal cerebrovascular disorders, pulmonary edema, severe anesthesia complications, sepsis, shock, sickle cell disease with crisis, air and thrombotic embolism blood products transfusion, hysterectomy, temporary tracheostomy, ventilation.

  8. Breastfeeding Initiation [Up to 12 months postpartum]

    Rates of breastfeeding initiation prior to discharge from the hospital

  9. Group-Based Medical Mistrust Scale [Baseline; Week 27 up to birth (third trimester); Birth up to Week 40 (Postpartum)]

    A 12-item validated survey focused on healthcare provided in the social context of racism and discrimination.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Self-reported Black or African American

  • Pregnant with singleton gestation

  • Has an established OBGY at Froedtert & the Medical College of Wisconsin (F&MCW) Health System

Exclusion Criteria:
  • Planning to deliver outside of F&MCW Health System

  • Receiving support beyond routing prenatal care, such as group prenatal care or has their own doula

  • Inability or unwillingness to provide informed consent

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Medical College of Wisconsin

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anna Palatnik, MD, Associate Professor, Medical College of Wisconsin
ClinicalTrials.gov Identifier:
NCT05993689
Other Study ID Numbers:
  • PRO00047801
First Posted:
Aug 15, 2023
Last Update Posted:
Aug 15, 2023
Last Verified:
Aug 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 15, 2023